46.71
price up icon0.06%   0.03
after-market アフターアワーズ: 46.71
loading
前日終値:
$46.68
開ける:
$46.68
24時間の取引高:
4.43M
Relative Volume:
0.94
時価総額:
$3.52B
収益:
-
当期純損益:
$-275.16M
株価収益率:
-12.01
EPS:
-3.89
ネットキャッシュフロー:
$-221.15M
1週間 パフォーマンス:
+0.49%
1か月 パフォーマンス:
+1.02%
6か月 パフォーマンス:
+12.61%
1年 パフォーマンス:
+9.62%
1日の値動き範囲:
Value
$46.66
$46.75
1週間の範囲:
Value
$46.46
$46.77
52週間の値動き範囲:
Value
$28.21
$62.00

Springworks Therapeutics Inc Stock (SWTX) Company Profile

Name
名前
Springworks Therapeutics Inc
Name
セクター
Healthcare (1170)
Name
電話
203-883-9490
Name
住所
100 WASHINGTON BOULEVARD, STAMFORD, CT
Name
職員
368
Name
Twitter
@springworkstx
Name
次回の収益日
2024-11-12
Name
最新のSEC提出書
Name
SWTX's Discussions on Twitter

SWTX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
SWTX
Springworks Therapeutics Inc
46.71 3.50B 0 -275.16M -221.15M -3.89
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Springworks Therapeutics Inc Stock (SWTX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-11-20 開始されました Evercore ISI Outperform
2024-02-05 開始されました Guggenheim Buy
2022-12-01 開始されました BofA Securities Buy
2021-01-19 繰り返されました H.C. Wainwright Buy
2020-10-29 繰り返されました H.C. Wainwright Buy
2020-05-05 開始されました Barclays Overweight
2020-03-19 アップグレード H.C. Wainwright Neutral → Buy
2020-03-04 ダウングレード H.C. Wainwright Buy → Neutral
2020-01-21 繰り返されました H.C. Wainwright Buy
2019-12-04 開始されました H.C. Wainwright Buy
2019-10-08 開始されました Cowen Outperform
2019-10-08 開始されました Goldman Buy
2019-10-08 開始されました JP Morgan Overweight
2019-10-08 開始されました Wedbush Outperform
すべてを表示

Springworks Therapeutics Inc (SWTX) 最新ニュース

pulisher
May 31, 2025

Nuveen Asset Management LLC Has $6.64 Million Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

May 31, 2025
pulisher
May 30, 2025

BNP Paribas Financial Markets Purchases Shares of 9,719 SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

May 30, 2025
pulisher
May 30, 2025

Promising Growth Stocks To Research – May 28th - Defense World

May 30, 2025
pulisher
May 29, 2025

ProShare Advisors LLC Has $827,000 Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

May 29, 2025
pulisher
May 28, 2025

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Given Average Recommendation of "Hold" by Analysts - MarketBeat

May 28, 2025
pulisher
May 28, 2025

Deutsche Bank AG Purchases 19,540 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

May 28, 2025
pulisher
May 28, 2025

Merck, SpringWorks receive German antitrust approval for their deal - MLex

May 28, 2025
pulisher
May 28, 2025

SpringWorks Therapeutics (NASDAQ:SWTX) Sees Unusually-High Trading VolumeHere's What Happened - MarketBeat

May 28, 2025
pulisher
May 28, 2025

Palisades Investment Partners LLC Purchases 12,154 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

May 28, 2025
pulisher
May 27, 2025

Bank of America Corp DE Reduces Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

May 27, 2025
pulisher
May 27, 2025

SpringWorks Therapeutics (SWTX) Surged on Acquisition News - Insider Monkey

May 27, 2025
pulisher
May 27, 2025

BNP Paribas Financial Markets Makes New $351,000 Investment in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - Defense World

May 27, 2025
pulisher
May 26, 2025

SpringWorks Gets CHMP Nod for Mirdametinib in Rare Disease - Nasdaq

May 26, 2025
pulisher
May 26, 2025

142,300 Shares in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Bought by Zimmer Partners LP - MarketBeat

May 26, 2025
pulisher
May 25, 2025

SpringWorks Therapeutics’ SWOT analysis: biotech stock faces acquisition challenges - Investing.com

May 25, 2025
pulisher
May 25, 2025

Growth Stocks To Consider – May 23rd - Defense World

May 25, 2025
pulisher
May 25, 2025

Growth Stocks To ConsiderMay 23rd - MarketBeat

May 25, 2025
pulisher
May 25, 2025

(SWTX) Investment Analysis - news.stocktradersdaily.com

May 25, 2025
pulisher
May 25, 2025

SpringWorks Therapeutics receives positive CHMP opinion for Mirdametinib for the treatment of adult and paediatric patients with NF1-PN | Health & Wellbeing | Lifestyle - The Phoenix Newspaper UK

May 25, 2025
pulisher
May 25, 2025

SpringWorks Therapeutics (NASDAQ:SWTX) Sees Large Volume Increase – Time to Buy? - Defense World

May 25, 2025
pulisher
May 25, 2025

Woodline Partners LP Raises Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

May 25, 2025
pulisher
May 24, 2025

SpringWorks Therapeutics erhält positive CHMP-Stellungnahme für Mirdametinib zur Behandlung erwachsener und pädiatrischer Patienten mit NF1-PN - GlobeNewswire Inc.

May 24, 2025
pulisher
May 24, 2025

Rafferty Asset Management LLC Has $4.44 Million Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

May 24, 2025
pulisher
May 24, 2025

Velan Capital Investment Management LP Acquires Shares of 185,520 SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

May 24, 2025
pulisher
May 24, 2025

Tema Etfs LLC Takes $1.11 Million Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

May 24, 2025
pulisher
May 23, 2025

SpringWorks’ drug nears EU approval for neurofibromatosis treatment By Investing.com - Investing.com South Africa

May 23, 2025
pulisher
May 23, 2025

SpringWorks Therapeutics (SWTX) Gains EMA Panel Support for Mird - GuruFocus

May 23, 2025
pulisher
May 23, 2025

SpringWorks gets EU endorsement for genetic disorder treatment - Seeking Alpha

May 23, 2025
pulisher
May 23, 2025

SpringWorks’ drug nears EU approval for neurofibromatosis treatment - Investing.com Australia

May 23, 2025
pulisher
May 23, 2025

Springworks Therapeutics Says Mirdametinib Recommended by EU Panel for Treating Plexiform Neurofibromas - marketscreener.com

May 23, 2025
pulisher
May 23, 2025

SpringWorks Therapeutics Receives Positive CHMP Opinion For Mirdametinib For The Treatment Of Adult And Pediatric Patients With NF1-PN - marketscreener.com

May 23, 2025
pulisher
May 23, 2025

SpringWorks: CHMP Adopts Positive Opinion For Mirdametinib - Nasdaq

May 23, 2025
pulisher
May 23, 2025

SpringWorks Therapeutics Receives Positive CHMP Opinion for Mirdametinib for the Treatment of Adult and Pediatric Patients with NF1-PN - The Manila Times

May 23, 2025
pulisher
May 23, 2025

SpringWorks Therapeutics Receives Positive CHMP Opinion for Mird - GuruFocus

May 23, 2025
pulisher
May 23, 2025

SpringWorks Therapeutics (SWTX) Receives Positive Opinion from E - GuruFocus

May 23, 2025
pulisher
May 23, 2025

SpringWorks Therapeutics Receives Positive CHMP Opinion for Mirdametinib for the Treatment of Adult and Pediatric Patients with NF1-PN | SWTX Stock News - GuruFocus

May 23, 2025
pulisher
May 23, 2025

SpringWorks Therapeutics (SWTX) Receives Positive Opinion from EMA for Mirdametinib | SWTX Stock News - GuruFocus

May 23, 2025
pulisher
May 23, 2025

SpringWorks Therapeutics Reports Positive CHMP Opinion for Mirdametinib as Potential First Therapy for NF1-PN in EU - Nasdaq

May 23, 2025
pulisher
May 23, 2025

SpringWorks Therapeutics Inc. (SWTX) Receives Positive CHMP Opinion for Mirdametinib for the Treatment of Adult and Pediatric Patients with NF1-PN - StreetInsider

May 23, 2025
pulisher
May 23, 2025

SpringWorks Therapeutics Receives Positive CHMP Opinion for - GlobeNewswire

May 23, 2025
pulisher
May 23, 2025

Breakthrough NF1-PN Treatment Scores 52% Response Rate in Children as EU Approval Looms - Stock Titan

May 23, 2025
pulisher
May 23, 2025

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Receives Consensus Recommendation of “Hold” from Analysts - Defense World

May 23, 2025
pulisher
May 23, 2025

Deutsche Bank AG Increases Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - Defense World

May 23, 2025
pulisher
May 22, 2025

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by Ensign Peak Advisors Inc - MarketBeat

May 22, 2025
pulisher
May 22, 2025

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by Bank of America Corp DE - Defense World

May 22, 2025
pulisher
May 21, 2025

Sphera Funds Management LTD. Acquires Shares of 100,000 SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

May 21, 2025
pulisher
May 19, 2025

D. E. Shaw & Co. Inc. Sells 336,949 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

May 19, 2025
pulisher
May 19, 2025

Patient Square Capital LP Buys Shares of 93,137 SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

May 19, 2025
pulisher
May 18, 2025

Northern Trust Corp Buys 52,908 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

May 18, 2025
pulisher
May 18, 2025

Ameriprise Financial Inc. Acquires 173,222 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

May 18, 2025
pulisher
May 18, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates - GlobeNewswire

May 18, 2025

Springworks Therapeutics Inc (SWTX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
大文字化:     |  ボリューム (24 時間):